Quarterly report pursuant to Section 13 or 15(d)

NOTE PAYABLE (Details Textual)

v3.3.1.900
NOTE PAYABLE (Details Textual) - USD ($)
 3 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Sep. 30, 2015
Sep. 30, 2013
Note Payable [Line Items]        
Interest Expense, Debt $ 2,765 $ 2,765    
Debt instrument, unamortized discount 969,589   $ 966,824  
Loans        
Note Payable [Line Items]        
Notes Payable 944,707      
2014 Warrant        
Note Payable [Line Items]        
Notes Payable $ 55,293      
Fair Value Assumptions, Risk Free Interest Rate 2.64%      
Fair Value Assumptions, Expected Dividend Rate 0.00%      
Fair Value Assumptions, Expected Term 10 years      
Fair Value Assumptions, Expected Volatility Rate 114.00%      
Massachusetts Life Sciences Center        
Note Payable [Line Items]        
Subordinated Debt $ 1,000,000     $ 1,000,000
Debt Instrument, Payment Terms The loan bears interest at a rate of 10% per annum, and will become fully due and payable on the earlier of (i) September 30, 2018, (ii) the occurrence of an event of default under the MLSC Loan Agreement, or (iii) the completion of a sale of substantially all of our assets, a change-of-control transaction or one or more financing transactions in which we receive from third parties other than our then existing shareholders net proceeds of $5,000,000 or more in a 12-month period.      
Warrants Issued To Purchase Of Common Stock       145,985
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 0.27